Biossil raises $153M in a venture round

Biossil is an applied AI drug discovery platform to create specialized treatments for distinct patients. The company announced a $153M venture round on September 28, 2026, from its base in Toronto, CA. Investors and valuation were not disclosed in Crunchbase's round record; Lounge adds them as they are reported. It has raised more than $100M in total venture funding.